RXL ETF Price & Analysis
RXL ETF Chart & Stats
56.35
--
Market closed
56.35
--
Day’s Range― - ―
52-Week Range36.23 - 56.35
Previous Close56.35
VolumeN/A
Average Volume (3M)8.65K
AUM78.89M
NAV53.50
Expense Ratio0.95%
Holdings Count61
Beta0.81
Inception DateJan 30, 2007
Last Dividend Ex-Date
Jun 24, 2026Dividend Yield
(1.26%)Shares OutstandingN/A
Standard DeviationN/A
10 Day Avg. Volume12,829
30 Day Avg. Volume8,649
AlphaN/A
ETF Overview
ProShares Ultra Health Care
ProShares Ultra Health Care (RXL) is an exchange-traded fund meticulously designed for those looking to capitalize on the dynamic opportunities within the health care sector. As a sector-focused ETF, RXL stands out by offering investors amplified exposure to the robust and ever-evolving health care industry. This fund seeks to provide twice the daily performance of the Dow Jones U.S. Health Care Index, allowing investors to leverage their investments to potentially achieve higher returns.
In a broad-based niche, ProShares Ultra Health Care covers a comprehensive range of health care sub-sectors, including pharmaceuticals, biotechnology, medical devices, and health care providers. This diversified yet concentrated approach makes RXL an attractive option for investors aiming to harness the growth potential from innovations and advancements in medical technology and health care services.
Whether you're looking to hedge existing health care positions or seeking a tactical investment to capitalize on short-term movements within the sector, RXL offers a compelling and efficient solution. With its focus on delivering leveraged exposure to health care, this ETF is tailored for investors with a strong conviction in the sector's growth trajectory and a higher risk tolerance.
ProShares Ultra Health Care (RXL) Fund Flow Chart
ProShares Ultra Health Care (RXL) 1 year Net Flows: -6M
RXL ETF News
RXL ETF FAQ
What was RXL’s price range in the past 12 months?
RXL lowest ETF price was 36.23 and its highest was 56.35 in the past 12 months.
What is the AUM of RXL?
As of Jul 01, 2026 The AUM of RXL is 78.89M.
Is RXL overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does RXL pay dividends?
RXL pays a Quarterly dividend of 0.177 which represents an annual dividend yield of 1.26%. See more information on RXL dividends here
How many shares outstanding does RXL have?
Currently, no data Available
Which hedge fund is a major shareholder of RXL?
Currently, no hedge funds are holding shares in RXL
Top 10 Holdings
U.S. Dollar
16.94%
Eli Lilly And Company
11.85%
ProShares GENIUS Money Market ETF
10.67%
Johnson & Johnson
7.69%
Abbvie
5.58%
Unitedhealth Group Inc.
4.87%
Merck & Company
3.89%
Amgen Inc
2.45%
Thermo Fisher Scientific
2.40%
Abbott Laboratories
2.02%
Total68.36%
See All Holdings

